Cowen and Company’s Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share CCV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-129,676
Closed -$10.5K 734
2022
Q4
$10.5K Buy
+129,676
New +$5.55K ﹤0.01% 407
2021
Q4
Sell
-25,000
Closed -$33K 814
2021
Q3
$33K Buy
+25,000
New +$36.3K ﹤0.01% 428

Other funds holding CCV.WS

Cowen and Company's CCV.WS Position: Q1 2023 in Review

Cowen and Company sold out of Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share (CCV.WS) in Q1 2023, closing a stake of 129,676 shares — an estimated $10.5K sold.

Cowen and Company first reported a position in CCV.WS in Q3 2021 and held it in 2 quarters. The position peaked at $33K in Q3 2021. 39 funds tracked by Wall St. Rank hold CCV.WS as of Q1 2023.

  • Cowen and Company reported no remaining Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 129,676 Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q1 2023, an estimated $10.5K.
  • Cowen and Company first reported a position in Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q3 2021 and held it in 2 quarters.
  • Cowen and Company's Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $33K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.